IPP Bureau
Imfinzi granted Priority Review and Breakthrough Therapy Designation in US
By IPP Bureau - July 31, 2025
For patients with resectable early-stage gastric and gastroesophageal junction cancers
Fortis and Agilus expand rapid genomic testing capabilities
By IPP Bureau - July 31, 2025
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
By IPP Bureau - July 31, 2025
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Asahi Kasei Life Science to construct new plant for Planova virus removal filters
By IPP Bureau - July 31, 2025
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Aurobindo to acquire Lannett Company for Rs. 2,185 Cr
By IPP Bureau - July 31, 2025
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Wallace Pharmaceuticals appoints Chinmaya Mohanty as VP & Head – Human Resources
By IPP Bureau - July 30, 2025
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
Ajanta Pharma reports Q1 FY26 consolidated PAT at Rs. 255.34 Cr
By IPP Bureau - July 30, 2025
Ajanta Pharma has reported total income of Rs. 1,328.98 crores during the period ended June 30, 2025
Vijaya Diagnostic reports Q1 FY26 consolidated PAT at Rs. 38.33 Cr
By IPP Bureau - July 30, 2025
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
Novartis India posts Q1 FY26 net profit at Rs. 27.62 Cr
By IPP Bureau - July 30, 2025
Novartis India has reported total income of Rs. 98.16 crores during the period ended June 30, 2025
Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr
By IPP Bureau - July 30, 2025
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Merck unveils $3 billion cost cutting plan
By IPP Bureau - July 30, 2025
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
Biocon Foundation and IISc commemorate World Head & Neck Cancer Day
By IPP Bureau - July 29, 2025
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Piramal Pharma reports Q1 FY26 consolidated loss at Rs. 81.70 Cr
By IPP Bureau - July 29, 2025
Piramal Pharma has reported total income of Rs. 1,992.11 crores during the period ended June 30, 2025
Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business
By IPP Bureau - July 29, 2025
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Torrent Pharmaceuticals appoints Aman Mehta as MD
By IPP Bureau - July 29, 2025
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
